IL-10 also regulates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) expression, with aberrant NF-κB activation and reduced IL-10 levels linked to IBD (Kaur and Goggolidou 2020). The gene discussed is NFKB1; the disease is inflammatory bowel disease.